Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-02

Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating efficacy, safety, and pharmacokinetics of ES-481 in adults with essential tremor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ES-481

Snippet

Sponsor: ES Therapeutics Australia Pty Ltd | Conditions: Tremor, Essential | Phase 2 | Status: UNKNOWN